文献速递神经肿瘤

恶性胶质瘤中组成性1型干扰素信号活性

Constitutive type-1 interferons signaling activity in malignant gliomas.
PubMed 文献 · J Neurooncol · 2024-05-24

本研究利用364例胶质瘤组织芯片的多重免疫荧光及TCGA和CGGA数据库生物信息学分析,探讨组成性1型干扰素(IFN-I)信号活性在胶质瘤中的异质性与临床意义。结果显示IFN-I活性随WHO恶性级别升高而增加、在IDH突变胶质瘤中降低,高IFN-I活性为不良预后的独立预测因素,并与胶质瘤相关炎症及肿瘤微环境细胞分布模式相关。

要点

  • 组成性IFN-I信号活性在胶质瘤亚型间高度异质。
  • 高IFN-I活性为不良结局的独立预测因素。
  • IFN-I活性与胶质瘤相关炎症及微环境细胞分布模式相关。

核心结论

  • 组成性IFN-I信号活性在胶质瘤亚型间差异显著,可能提示胶质瘤炎症增加和不良临床结局。

研究设计与样本

  • 对本队列364例胶质瘤组织芯片进行多重免疫荧光(mIF)分析。
  • 对癌症基因组图谱(TCGA)和中国胶质瘤基因组图谱(CGGA)数据库进行生物信息学分析。

主要发现

  • 组成性IFN-I信号活性在胶质瘤亚型间高度异质。
  • 信号活性随WHO恶性级别升高而增加,在IDH突变胶质瘤中降低。
  • 高IFN-I活性为不良结局的独立预测因素。
  • IDH突变胶质瘤中全局DNA高甲基化与IFN-I信号活性降低相关。
  • IFN-I活性与胶质瘤相关炎症(包括抗肿瘤和促肿瘤免疫反应)呈正相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent studies revealed a pro-tumor effect of constitutive Type-1 interferons (IFN-I) production and the downstream signaling activity in several malignancies. In contrast, heterogeneity and clinical significance of the signaling activity in gliomas remain unknown. Thus, we aimed to depict the heterogeneity and clinical significance of constitutive Type-1 interferon (IFN-I) production and the downstream signaling activity in gliomas. METHODS: We utilized multiplex immunofluorescence (mIF) on a 364 gliomas tissue microarray from our cohort. Moreover, we conducted bioinformatic analyses on the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to investigate the heterogeneity and clinical significance of constitutive IFN-I signaling activity in gliomas. RESULTS: We observed high heterogeneity of the constitutive IFN-I signaling activity among glioma subtypes. Signaling increased with the WHO malignancy grade while decreasing in the gliomas with IDH mutations. Additionally, high IFN-I activity served as an independent predictor of unfavorable outcomes, and global DNA hypermethylation in IDH-mutant gliomas was associated with decreased IFN-I signaling activity. Positive correlations were observed between the IFN-I activity and glioma-associated inflammation, encompassing both anti-tumor and pro-tumor immune responses. Furthermore, the IFN-I activity varied significantly among tumor and immune cells in the glioma microenvironment (GME). Notably, a distinct pattern of IFN-I signaling activity distribution in GME cells was observed among glioma subtypes, and the pattern was independently associated with patient overall survival. CONCLUSIONS: Constitutive IFN-I signaling activity varies significantly among glioma subtypes and represents a potential indicator for increased glioma inflammation and unfavorable clinical outcomes.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Li C, Long L, Wang Y, et al. Constitutive type-1 interferons signaling activity in malignant gliomas. J Neurooncol. 2024. PMID: 38789844. doi:10.1007/s11060-024-04601-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。